Kliogest (Norethisterone Acetate, Estradiol)

Norethisterone acetate acts as a synthetic progestogen, binding to progesterone receptors, while estradiol provides estrogenic activity by binding to estrogen receptors. Together they suppress the hypothalamic‑pituitary‑ovarian axis, inhibit the LH surge, prevent ovulation, thicken cervical mucus, and stabilize the endometrial lining, creating conditions that prevent fertilization and implantation.

The dosing regimen for Kliogest is determined by the prescribing healthcare professional based on individual patient needs and clinical guidelines. Typically, it is taken once daily at the same time each day, but the exact number of tablets, cycle length, and any hormone‑free interval are set by the prescriber.

Kliogest is contraindicated in pregnancy because its hormonal components can affect fetal development. Women who become pregnant while using the product should discontinue it immediately. During breastfeeding, the estrogen component may reduce milk production, and the risk‑benefit profile should be evaluated by a healthcare provider before use.

To order Kliogest, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling) and the necessary import documentation.

Kliogest contains the specific combination of norethisterone acetate and estradiol, which offers a balance of progestogenic and estrogenic activity similar to many other combined oral contraceptives. Compared with formulations that use ethinyl‑estradiol, estradiol may have a slightly different metabolic profile and may be preferred in patients seeking a more natural estrogen component, though efficacy and safety remain comparable when used as directed.

Kliogest tablets should be stored at room temperature, below 25 °C, in the original blister pack or container. Protect them from moisture, excessive heat, and direct sunlight. Keep the product out of reach of children and do not use tablets that appear discolored or damaged.

Kliogest is taken orally, usually once daily at the same time each day. The tablet is swallowed whole with water and should be taken with or without food as directed by the prescriber. Consistency in timing helps maintain stable hormone levels and maximizes contraceptive effectiveness.

The most serious risks associated with Kliogest include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, stroke, myocardial infarction, severe hypertension, and rare liver disorders. Patients should seek immediate medical attention if they experience sudden chest pain, shortness of breath, severe headache, visual changes, or unexplained swelling of the legs.

Kliogest should not be used by women with a history of thromboembolic disease, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or those who are pregnant. It is also contraindicated in smokers over the age of 35 and in individuals taking medications that significantly reduce its effectiveness, such as strong enzyme inducers.